Laurus Labs Intrinsic Value
Laurus Labs intrinsic value. Laurus Labs (LAURUSLABS) median intrinsic value is ₹1005.74 from 10 valuation models (range ₹601–₹2043), vs current price ₹2002.50 — -49.8% downside (Trading Above Calculated Value), margin of safety -99.1%. Compare with LAURUSLABS fair value to assess whether the stock is under or overvalued.
LAURUSLABS Valuation Methods Summary — DCF, Graham Number & P/E
Laurus Labs intrinsic value across 10 models vs current price ₹2002.50 — upside/downside and value range per method. For current market price and key ratios, visit LAURUSLABS screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹600.75 | ₹480.60 - ₹720.90 | -70.0% | EPS: ₹20.68, Sector P/E: 22x |
| Book Value Method | asset | ₹1005.74 | ₹905.17 - ₹1106.31 | -49.8% | Book Value/Share: ₹502.87, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1350.37 | ₹1215.33 - ₹1485.41 | -32.6% | Revenue/Share: ₹675.19, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1940.74 | ₹1746.67 - ₹2134.81 | -3.1% | EBITDA: ₹2096.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹2042.53 | ₹1634.02 - ₹2451.04 | +2.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹600.75 | ₹540.68 - ₹660.83 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹600.75 | ₹540.68 - ₹660.83 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹1671.11 | ₹1504.00 - ₹1838.22 | -16.5% | ROE: 20.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹600.75 | ₹540.68 - ₹660.83 | -70.0% | EPS: ₹20.68, BVPS: ₹502.87 |
| Dividend Yield Method | dividend | ₹600.75 | ₹540.68 - ₹660.83 | -70.0% | DPS: ₹2.00, Target Yield: 2.5% |
LAURUSLABS Intrinsic Value vs Market Price — All Valuation Models
Laurus Labs fair value range ₹601–₹2043 vs current market price ₹2002.50 across 10 valuation models. Read LAURUSLABS dividend history for the complete payout history and dividend yield track record.
LAURUSLABS Intrinsic Value Analysis — Undervalued or Overvalued?
Laurus Labs median intrinsic value ₹1005.74, current price ₹2002.50 — Trading Above Calculated Value by 49.8%, margin of safety -99.1%.
What is the intrinsic value of LAURUSLABS?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Laurus Labs (LAURUSLABS) is ₹1005.74 (median value). With the current market price of ₹2002.50, this represents a -49.8% variance from our estimated fair value.
The valuation range spans from ₹600.75 to ₹2042.53, indicating ₹600.75 - ₹2042.53.
Is LAURUSLABS undervalued or overvalued?
Based on our multi-method analysis, Laurus Labs (LAURUSLABS) appears to be trading above calculated value by approximately 49.8%.
LAURUSLABS Financial Health — Key Ratios vs Industry Benchmarks
Laurus Labs financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 20.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 28.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.69x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
LAURUSLABS Cash Flow Quality — Operating & Free Cash Flow
Laurus Labs operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹1,624 Cr | ₹1,081 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹602 Cr | ₹262 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹666 Cr | ₹255 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹994 Cr | ₹496 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹911 Cr | ₹454 Cr | Positive Free Cash Flow | 7/10 |